GELS - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים Gelteq Limited

The investment attractiveness of Gelteq Limited (GELS) is based on the trust physicians place in their convenient pediatric drug formulations. This chart on GURU.Markets illustrates the rolling annual change in sales volume, where the value -100.10 reflects the metric's balance. Efficiency is confirmed by a lean R&D staff and the complete outsourcing of drug synthesis to external contract manufacturers.
Gelteq Ltd (GELS) - פילוחי מדדים ודוחות פיננסיים

This indicator reflects revenue dynamics over the last twelve months relative to the same period last year. By analyzing the TTM revenue growth rate, an investor assesses the real pace of business expansion, stripped of seasonal fluctuations. A positive trajectory confirms sustainable market demand and the effectiveness of the commercial strategy. For Gelteq Limited (GELS), this indicates the scaling of its unique gel-based drug delivery technology. The company's patent moat is converting into real financial growth by replacing traditional injections.